Epigenetics Market Growth & Trends
The global epigenetics market size is expected to reach USD 39.15 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030. The market is being driven by factors, such as the rise in funding, investment & regulatory approvals for epigenetics research & development, the expansion of the use of epigenetic enzymes in drug discovery & development, and the decreasing cost of genome sequencing. Since epigenetics has demonstrated beneficial applications outside of cancer, commercial expansion is envisaged.The rising demand for understanding epigenetic alterations at the molecular level, as well as the advancement of medicinal treatments, would likely push these organizations to support research and development programs.
Furthermore, initiatives, such as the Epidemiology and Genomics Research Program (EGRP), provide incentives for research efforts aimed at better-comprehending cancer genesis and consequences.A few organizations that help fuel the market's rise are the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH). These organizations support funding and help for initiatives involving product development and R&D in the field of epigenetics. For instance, the National Institutes of Health aggressively promotes cutting-edge epigenetic research worldwide through its common fund epigenomics program.
Epigenetics Market Report Highlights
- By product, the reagents segment dominated the industry, accounting for 33.45% of the global revenue in 2023. The large share of this segment can be attributed to the high usage of reagents in epigenetic research studies.
- By technology, the DNA methylation segment dominated the market with a revenue share of 45.36% in 2023. DNA methylation's demand in epigenetics stems from its pivotal role in gene expression regulation.
- By application, the oncology segment dominated the market with a revenue share of 69.06% in 2023. Oncology's demand for epigenetics arises from the intricate relationship between epigenetic alterations and cancer development.
- North America dominated the market and accounted for a 38.19% share in 2023. The region experiences growth due to heightened public awareness, robust medical facilities, and substantial R&D investments.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. End-use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal Database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective - 1
1.10.2. Objective - 2
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. End-use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal Database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective - 1
1.10.2. Objective - 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Epigenetics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Rising geriatric patient population
3.2.1.3. Increasing government initiatives
3.2.2. Market restraint analysis
3.2.2.1. Lack of standardization in epigenetics-based diagnostics
3.2.2.2. Lack of skilled professionals
3.2.3. Market opportunity analysis
3.2.3.1. Improving healthcare infrastructure in developing economies
3.3. Epigenetics Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Rising geriatric patient population
3.2.1.3. Increasing government initiatives
3.2.2. Market restraint analysis
3.2.2.1. Lack of standardization in epigenetics-based diagnostics
3.2.2.2. Lack of skilled professionals
3.2.3. Market opportunity analysis
3.2.3.1. Improving healthcare infrastructure in developing economies
3.3. Epigenetics Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Epigenetics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Epigenetics Market Product Movement Analysis
4.3. Global Epigenetics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Kits
4.5.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. ChIP sequencing Kit
4.5.2.1. ChIP sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Whole Genomic Amplification Kit
4.5.3.1. Whole genomic amplification kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Bisulfite Conversion Kit
4.5.4.1. Bisulfite conversion kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. RNA sequencing Kit
4.5.5.1. RNA sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Others
4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Instruments
4.6.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Enzymes
4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Services
4.8.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Global Epigenetics Market Product Movement Analysis
4.3. Global Epigenetics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Kits
4.5.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. ChIP sequencing Kit
4.5.2.1. ChIP sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Whole Genomic Amplification Kit
4.5.3.1. Whole genomic amplification kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Bisulfite Conversion Kit
4.5.4.1. Bisulfite conversion kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. RNA sequencing Kit
4.5.5.1. RNA sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Others
4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Instruments
4.6.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Enzymes
4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Services
4.8.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Epigenetics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Epigenetics Market Technology Movement Analysis
5.3. Global Epigenetics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. DNA Methylation
5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Histone Methylation
5.5.1. Histone methylation market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Histone Acetylation
5.6.1. Histone Acetylation Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Large non-coding RNA
5.7.1. Large non-coding RNA market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MicroRNA modification
5.8.1. MicroRNA modification market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Chromatin structures
5.9.1. Chromatin structures market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Global Epigenetics Market Technology Movement Analysis
5.3. Global Epigenetics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. DNA Methylation
5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Histone Methylation
5.5.1. Histone methylation market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Histone Acetylation
5.6.1. Histone Acetylation Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Large non-coding RNA
5.7.1. Large non-coding RNA market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MicroRNA modification
5.8.1. MicroRNA modification market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Chromatin structures
5.9.1. Chromatin structures market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Epigenetics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Epigenetics Market Application Movement Analysis
6.3. Global Epigenetics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Oncology
6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Solid tumors
6.4.2.1. Solid tumors market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Liquid tumors
6.4.3.1. Liquid tumors market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Non-oncology
6.5.1. Non-oncology Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Inflammatory diseases
6.5.2.1. Inflammatory diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Metabolic diseases
6.5.3.1. Metabolic diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Infectious diseases
6.5.4.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Cardiovascular diseases
6.5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Others
6.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Global Epigenetics Market Application Movement Analysis
6.3. Global Epigenetics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Oncology
6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Solid tumors
6.4.2.1. Solid tumors market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Liquid tumors
6.4.3.1. Liquid tumors market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Non-oncology
6.5.1. Non-oncology Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Inflammatory diseases
6.5.2.1. Inflammatory diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Metabolic diseases
6.5.3.1. Metabolic diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Infectious diseases
6.5.4.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Cardiovascular diseases
6.5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Others
6.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Epigenetics Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Epigenetics Market End-use Movement Analysis
7.3. Global Epigenetics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Academic Research
7.4.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Clinical Research
7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Hospitals & Clinics
7.6.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Pharmaceutical & Biotechnology Companies
7.7.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Other Users
7.8.1. Other users market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Global Epigenetics Market End-use Movement Analysis
7.3. Global Epigenetics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Academic Research
7.4.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Clinical Research
7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Hospitals & Clinics
7.6.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Pharmaceutical & Biotechnology Companies
7.7.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Other Users
7.8.1. Other users market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Epigenetics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
8.4. North America
8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Target disease prevalence
8.4.2.4. Competitive scenario
8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Target disease prevalence
8.4.3.4. Competitive scenario
8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Target disease prevalence
8.5.2.4. Competitive scenario
8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Target disease prevalence
8.5.3.4. Competitive scenario
8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Target disease prevalence
8.5.4.4. Competitive scenario
8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Target disease prevalence
8.5.5.4. Competitive scenario
8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Target disease prevalence
8.5.6.4. Competitive scenario
8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Target disease prevalence
8.5.7.4. Competitive scenario
8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Target disease prevalence
8.5.8.3. Regulatory framework
8.5.8.4. Competitive scenario
8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Target disease prevalence
8.5.9.4. Competitive scenario
8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Target disease prevalence
8.6.2.4. Competitive scenario
8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Target disease prevalence
8.6.3.4. Competitive scenario
8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Target disease prevalence
8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Target disease prevalence
8.6.5.4. Competitive scenario
8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Target disease prevalence
8.6.6.4. Competitive scenario
8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Target disease prevalence
8.6.7.3. Regulatory framework
8.6.7.4. Competitive scenario
8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Target disease prevalence
8.7.2.4. Competitive scenario
8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. Mexico
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Target disease prevalence
8.7.3.4. Competitive scenario
8.7.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Argentina
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Target disease prevalence
8.7.4.4. Competitive scenario
8.7.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Target disease prevalence
8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Target disease prevalence
8.8.3.4. Competitive scenario
8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Target disease prevalence
8.8.4.4. Competitive scenario
8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Target disease prevalence
8.8.5.4. Competitive scenario
8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
8.4. North America
8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Target disease prevalence
8.4.2.4. Competitive scenario
8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Target disease prevalence
8.4.3.4. Competitive scenario
8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Target disease prevalence
8.5.2.4. Competitive scenario
8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Target disease prevalence
8.5.3.4. Competitive scenario
8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Target disease prevalence
8.5.4.4. Competitive scenario
8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Target disease prevalence
8.5.5.4. Competitive scenario
8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Target disease prevalence
8.5.6.4. Competitive scenario
8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Target disease prevalence
8.5.7.4. Competitive scenario
8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Target disease prevalence
8.5.8.3. Regulatory framework
8.5.8.4. Competitive scenario
8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Target disease prevalence
8.5.9.4. Competitive scenario
8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Target disease prevalence
8.6.2.4. Competitive scenario
8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Target disease prevalence
8.6.3.4. Competitive scenario
8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Target disease prevalence
8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Target disease prevalence
8.6.5.4. Competitive scenario
8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Target disease prevalence
8.6.6.4. Competitive scenario
8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Target disease prevalence
8.6.7.3. Regulatory framework
8.6.7.4. Competitive scenario
8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Target disease prevalence
8.7.2.4. Competitive scenario
8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. Mexico
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Target disease prevalence
8.7.3.4. Competitive scenario
8.7.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Argentina
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Target disease prevalence
8.7.4.4. Competitive scenario
8.7.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Target disease prevalence
8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Target disease prevalence
8.8.3.4. Competitive scenario
8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Target disease prevalence
8.8.4.4. Competitive scenario
8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Target disease prevalence
8.8.5.4. Competitive scenario
8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Thermo Fisher Scientific Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Eisai Co., Ltd.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Novartis AG
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. ELEMENT BIOSCIENCES.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Dovetail Genomics.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Illumina, Inc.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Promega Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Abcam plc
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Thermo Fisher Scientific Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Eisai Co., Ltd.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Novartis AG
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. ELEMENT BIOSCIENCES.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Dovetail Genomics.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Illumina, Inc.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Promega Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Abcam plc
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global epigenetics market, by region, 2018 - 2030 (USD Million)
Table 3 Global epigenetics market, by product, 2018 - 2030 (USD Million)
Table 4 Global epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 5 Global epigenetics market, by application, 2018 - 2030 (USD Million)
Table 6 Global epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America epigenetics market, by country, 2018 - 2030 (USD Million)
Table 8 North America epigenetics market, by product, 2018 - 2030 (USD Million)
Table 9 North America epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 10 North America epigenetics market, by application, 2018 - 2030 (USD Million)
Table 11 North America epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 12 U.S. epigenetics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. epigenetics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 16 Canada epigenetics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada epigenetics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 20 Europe epigenetics market, by country, 2018 - 2030 (USD Million)
Table 21 Europe epigenetics market, by product, 2018 - 2030 (USD Million)
Table 22 Europe epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 23 Europe epigenetics market, by application, 2018 - 2030 (USD Million)
Table 24 Europe epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 25 Germany epigenetics market, by product, 2018 - 2030 (USD Million)
Table 26 Germany epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 27 Germany epigenetics market, by application, 2018 - 2030 (USD Million)
Table 28 Germany epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 29 UK epigenetics market, by product, 2018 - 2030 (USD Million)
Table 30 UK epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 31 UK epigenetics market, by application, 2018 - 2030 (USD Million)
Table 32 UK epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 33 France epigenetics market, by product, 2018 - 2030 (USD Million)
Table 34 France epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 35 France epigenetics market, by application, 2018 - 2030 (USD Million)
Table 36 France epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Italy epigenetics market, by product, 2018 - 2030 (USD Million)
Table 38 Italy epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 39 Italy epigenetics market, by application, 2018 - 2030 (USD Million)
Table 40 Italy epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 41 Spain epigenetics market, by product, 2018 - 2030 (USD Million)
Table 42 Spain epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 43 Spain epigenetics market, by application, 2018 - 2030 (USD Million)
Table 44 Spain epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 45 Denmark epigenetics market, by product, 2018 - 2030 (USD Million)
Table 46 Denmark epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 47 Denmark epigenetics market, by application, 2018 - 2030 (USD Million)
Table 48 Denmark epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 49 Sweden epigenetics market, by product, 2018 - 2030 (USD Million)
Table 50 Sweden epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 51 Sweden epigenetics market, by application, 2018 - 2030 (USD Million)
Table 52 Sweden epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 53 Norway epigenetics market, by product, 2018 - 2030 (USD Million)
Table 54 Norway epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 55 Norway epigenetics market, by application, 2018 - 2030 (USD Million)
Table 56 Norway epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 57 Asia Pacific epigenetics market, by country, 2018 - 2030 (USD Million)
Table 58 Asia Pacific epigenetics market, by product, 2018 - 2030 (USD Million)
Table 59 Asia Pacific epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 60 Asia Pacific epigenetics market, by application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 62 China epigenetics market, by product, 2018 - 2030 (USD Million)
Table 63 China epigenetics market, by application, 2018 - 2030 (USD Million)
Table 64 China epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 65 China epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 66 Japan epigenetics market, by product, 2018 - 2030 (USD Million)
Table 67 Japan epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 68 Japan epigenetics market, by application, 2018 - 2030 (USD Million)
Table 69 Japan epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 70 India epigenetics market, by product, 2018 - 2030 (USD Million)
Table 71 India epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 72 India epigenetics market, by application, 2018 - 2030 (USD Million)
Table 73 India epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 74 South Korea epigenetics market, by product, 2018 - 2030 (USD Million)
Table 75 South Korea epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 76 South Korea epigenetics market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 78 Australia epigenetics market, by product, 2018 - 2030 (USD Million)
Table 79 Australia epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 80 Australia epigenetics market, by application, 2018 - 2030 (USD Million)
Table 81 Australia epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 82 Thailand epigenetics market, by product, 2018 - 2030 (USD Million)
Table 83 Thailand epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 84 Thailand epigenetics market, by application, 2018 - 2030 (USD Million)
Table 85 Thailand epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 86 Latin America epigenetics market, by country, 2018 - 2030 (USD Million)
Table 87 Latin America epigenetics market, by product, 2018 - 2030 (USD Million)
Table 88 Latin America epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 89 Latin America epigenetics market, by application, 2018 - 2030 (USD Million)
Table 90 Latin America epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 91 Brazil epigenetics market, by product, 2018 - 2030 (USD Million)
Table 92 Brazil epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 93 Brazil epigenetics market, by application, 2018 - 2030 (USD Million)
Table 94 Brazil epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 95 Mexico epigenetics market, by product, 2018 - 2030 (USD Million)
Table 96 Mexico epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 97 Mexico epigenetics market, by application, 2018 - 2030 (USD Million)
Table 98 Mexico epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 99 Argentina epigenetics market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 101 Argentina epigenetics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 103 MEA epigenetics market, by country, 2018 - 2030 (USD Million)
Table 104 MEA epigenetics market, by product, 2018 - 2030 (USD Million)
Table 105 MEA epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 106 MEA epigenetics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 108 South Africa epigenetics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 110 South Africa epigenetics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia epigenetics market, by product, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia epigenetics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 116 UAE epigenetics market, by product, 2018 - 2030 (USD Million)
Table 117 UAE epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 118 UAE epigenetics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 120 Kuwait epigenetics market, by product, 2018 - 2030 (USD Million)
Table 121 Kuwait epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 122 Kuwait epigenetics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 2 Global epigenetics market, by region, 2018 - 2030 (USD Million)
Table 3 Global epigenetics market, by product, 2018 - 2030 (USD Million)
Table 4 Global epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 5 Global epigenetics market, by application, 2018 - 2030 (USD Million)
Table 6 Global epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America epigenetics market, by country, 2018 - 2030 (USD Million)
Table 8 North America epigenetics market, by product, 2018 - 2030 (USD Million)
Table 9 North America epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 10 North America epigenetics market, by application, 2018 - 2030 (USD Million)
Table 11 North America epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 12 U.S. epigenetics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. epigenetics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 16 Canada epigenetics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada epigenetics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 20 Europe epigenetics market, by country, 2018 - 2030 (USD Million)
Table 21 Europe epigenetics market, by product, 2018 - 2030 (USD Million)
Table 22 Europe epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 23 Europe epigenetics market, by application, 2018 - 2030 (USD Million)
Table 24 Europe epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 25 Germany epigenetics market, by product, 2018 - 2030 (USD Million)
Table 26 Germany epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 27 Germany epigenetics market, by application, 2018 - 2030 (USD Million)
Table 28 Germany epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 29 UK epigenetics market, by product, 2018 - 2030 (USD Million)
Table 30 UK epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 31 UK epigenetics market, by application, 2018 - 2030 (USD Million)
Table 32 UK epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 33 France epigenetics market, by product, 2018 - 2030 (USD Million)
Table 34 France epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 35 France epigenetics market, by application, 2018 - 2030 (USD Million)
Table 36 France epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Italy epigenetics market, by product, 2018 - 2030 (USD Million)
Table 38 Italy epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 39 Italy epigenetics market, by application, 2018 - 2030 (USD Million)
Table 40 Italy epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 41 Spain epigenetics market, by product, 2018 - 2030 (USD Million)
Table 42 Spain epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 43 Spain epigenetics market, by application, 2018 - 2030 (USD Million)
Table 44 Spain epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 45 Denmark epigenetics market, by product, 2018 - 2030 (USD Million)
Table 46 Denmark epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 47 Denmark epigenetics market, by application, 2018 - 2030 (USD Million)
Table 48 Denmark epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 49 Sweden epigenetics market, by product, 2018 - 2030 (USD Million)
Table 50 Sweden epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 51 Sweden epigenetics market, by application, 2018 - 2030 (USD Million)
Table 52 Sweden epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 53 Norway epigenetics market, by product, 2018 - 2030 (USD Million)
Table 54 Norway epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 55 Norway epigenetics market, by application, 2018 - 2030 (USD Million)
Table 56 Norway epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 57 Asia Pacific epigenetics market, by country, 2018 - 2030 (USD Million)
Table 58 Asia Pacific epigenetics market, by product, 2018 - 2030 (USD Million)
Table 59 Asia Pacific epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 60 Asia Pacific epigenetics market, by application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 62 China epigenetics market, by product, 2018 - 2030 (USD Million)
Table 63 China epigenetics market, by application, 2018 - 2030 (USD Million)
Table 64 China epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 65 China epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 66 Japan epigenetics market, by product, 2018 - 2030 (USD Million)
Table 67 Japan epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 68 Japan epigenetics market, by application, 2018 - 2030 (USD Million)
Table 69 Japan epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 70 India epigenetics market, by product, 2018 - 2030 (USD Million)
Table 71 India epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 72 India epigenetics market, by application, 2018 - 2030 (USD Million)
Table 73 India epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 74 South Korea epigenetics market, by product, 2018 - 2030 (USD Million)
Table 75 South Korea epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 76 South Korea epigenetics market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 78 Australia epigenetics market, by product, 2018 - 2030 (USD Million)
Table 79 Australia epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 80 Australia epigenetics market, by application, 2018 - 2030 (USD Million)
Table 81 Australia epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 82 Thailand epigenetics market, by product, 2018 - 2030 (USD Million)
Table 83 Thailand epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 84 Thailand epigenetics market, by application, 2018 - 2030 (USD Million)
Table 85 Thailand epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 86 Latin America epigenetics market, by country, 2018 - 2030 (USD Million)
Table 87 Latin America epigenetics market, by product, 2018 - 2030 (USD Million)
Table 88 Latin America epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 89 Latin America epigenetics market, by application, 2018 - 2030 (USD Million)
Table 90 Latin America epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 91 Brazil epigenetics market, by product, 2018 - 2030 (USD Million)
Table 92 Brazil epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 93 Brazil epigenetics market, by application, 2018 - 2030 (USD Million)
Table 94 Brazil epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 95 Mexico epigenetics market, by product, 2018 - 2030 (USD Million)
Table 96 Mexico epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 97 Mexico epigenetics market, by application, 2018 - 2030 (USD Million)
Table 98 Mexico epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 99 Argentina epigenetics market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 101 Argentina epigenetics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 103 MEA epigenetics market, by country, 2018 - 2030 (USD Million)
Table 104 MEA epigenetics market, by product, 2018 - 2030 (USD Million)
Table 105 MEA epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 106 MEA epigenetics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 108 South Africa epigenetics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 110 South Africa epigenetics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia epigenetics market, by product, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia epigenetics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 116 UAE epigenetics market, by product, 2018 - 2030 (USD Million)
Table 117 UAE epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 118 UAE epigenetics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE epigenetics market, by end-use, 2018 - 2030 (USD Million)
Table 120 Kuwait epigenetics market, by product, 2018 - 2030 (USD Million)
Table 121 Kuwait epigenetics market, by technology, 2018 - 2030 (USD Million)
Table 122 Kuwait epigenetics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait epigenetics market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Epigenetics market: Market outlook
Fig. 5 Epigenetics market: Segment outlook
Fig. 6 Epigenetics market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Epigenetics market driver impact
Fig. 9 Epigenetics market restraint impact
Fig. 10 Epigenetics market: Product outlook and key takeaways
Fig. 11 Epigenetics market: Product movement analysis
Fig. 12 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 ChIP sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Whole genomic amplification kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Bisulfite conversion kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 RNA sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Epigenetics market: Technology outlook and key takeaways
Fig. 23 Epigenetics market: Technology movement analysis
Fig. 24 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Histone methylation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Histone acetylation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Large non-coding RNA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 MicroRNA modification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Chromatin structures market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Epigenetics market: Application outlook and key takeaways
Fig. 31 Epigenetics market: Application movement analysis
Fig. 32 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Solid tumors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Liquid tumors market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 35 Non-oncology market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 36 Inflammatory diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 37 Metabolic diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 38 Infectious diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 39 Cardiovascular diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Epigenetics market: End-use outlook and key takeaways
Fig. 42 Epigenetics market: End-use movement analysis
Fig. 43 Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Clinical research market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 45 Hospitals & Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 47 Other users market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Global epigenetics market: Regional outlook and key takeaways
Fig. 49 Global epigenetics market: Regional movement analysis
Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Epigenetics market: Market outlook
Fig. 5 Epigenetics market: Segment outlook
Fig. 6 Epigenetics market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Epigenetics market driver impact
Fig. 9 Epigenetics market restraint impact
Fig. 10 Epigenetics market: Product outlook and key takeaways
Fig. 11 Epigenetics market: Product movement analysis
Fig. 12 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 ChIP sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Whole genomic amplification kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Bisulfite conversion kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 RNA sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Epigenetics market: Technology outlook and key takeaways
Fig. 23 Epigenetics market: Technology movement analysis
Fig. 24 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Histone methylation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Histone acetylation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Large non-coding RNA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 MicroRNA modification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Chromatin structures market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Epigenetics market: Application outlook and key takeaways
Fig. 31 Epigenetics market: Application movement analysis
Fig. 32 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Solid tumors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Liquid tumors market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 35 Non-oncology market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 36 Inflammatory diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 37 Metabolic diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 38 Infectious diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 39 Cardiovascular diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Epigenetics market: End-use outlook and key takeaways
Fig. 42 Epigenetics market: End-use movement analysis
Fig. 43 Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Clinical research market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 45 Hospitals & Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 47 Other users market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Global epigenetics market: Regional outlook and key takeaways
Fig. 49 Global epigenetics market: Regional movement analysis
Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Eisai Co., Ltd.
- Novartis AG
- ELEMENT BIOSCIENCES.
- Dovetail Genomics.
- Illumina, Inc.
- Promega Corporation
- Abcam plc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | April 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 14.63 Billion |
| Forecasted Market Value ( USD | $ 39.15 Billion |
| Compound Annual Growth Rate | 15.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
